In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Curaxis Pharmaceutical Corp.

www.curaxispharma.com

Latest From Curaxis Pharmaceutical Corp.

No Dilution Necessary: The Promise of Project Financing

Project financing, claim its proponents-in particular Symphony Capital-offers an alternative to highly dilutive equity offerings, preserving the upside from the development of a successful product for the biotech. That's true, though this expensive capital isn't for everyone. Yet as Big Pharma's productivity challenge deepens, project financing is helping to swing the balance of power further towards small companies.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Voyager Pharmaceutical Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Curaxis Pharmaceutical Corp.
  • Senior Management
  • Patrick S Smith, Pres. & CEO
    David J Corcoran, CFO & EVP
  • Contact Info
  • Curaxis Pharmaceutical Corp.
    Phone: (678) 566-3750
    12600 Deerfield Pkwy.
    Ste. 100
    Alpharetta, GA 30004
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register